To the Editor We apologize to the editors and readers of JAMA Psychiatry for our failure to fully disclose our financial interests in an article1 that reported a diagnostic tool, the Computerized Adaptive Test for Depression (CAT-DI). Following acceptance of the paper, we disclosed that “The CAT-DI will ultimately be made available for routine administration, and its development as a commercial product is under consideration.” The company that owns the rights to CAT-DI and several related tests is Psychiatric Assessments, Inc (PAI), which uses the trade name of Adaptive Testing Technologies (ATT) on a website describing these tests.
Gibbons RD, Weiss DJ, Pilkonis PA, Frank E, Kupfer DJ. Failure to Report Financial Disclosure Information. JAMA Psychiatry. 2014;71(1):95. doi:10.1001/jamapsychiatry.2013.3888
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: